DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Morgan Stanley Maintains Overweight on Radius Health, Lowers Price Target to $33

Morgan Stanley maintains Radius Health (NASDAQ:RDUS) with a Overweight and lowers the price target from $36 to $33.

Benzinga · 03/06/2020 14:36

Morgan Stanley maintains Radius Health (NASDAQ:RDUS) with a Overweight and lowers the price target from $36 to $33.